Cancer—basal cell carcinoma (BCC), squamous cell carcinoma (SCC), and melanoma.
2023
Dr DePalo on First-Line Therapies in Unresectable Melanoma In-Transit Metastases
Danielle K. DePalo, MD, Moffitt Cancer Center, discusses findings from a study comparing first-line isolated limb infusion/perfusion vs immune checkpoint inhibitors and intratumoral therapy in patients with surgically unresectable melanoma in-transit metastases.
Researchers advocate for promotion of skin self-examination for early melanoma detection
62.5% of 128 patients were diagnosed with a melanoma less than 1 mm thick after having conducted skin self-examinations (SSE).
Acral Lentiginous Melanoma More Common in Southeast Asian Patients Than Other Asian American & Pacific Islander Groups
A poster presentation from the 19th Annual Skin of Color Society Scientific Symposium analyzed the differences in presentation of cutaneous melanoma among Asian American and Pacific Islander patients.